Clinicians
OVERVIEW
The Abilitech Assist device, launching in 2020, is a one-of-a-kind wearable assistive device that supports patients with upper-limb weakness or injury to perform independent activities of daily living. The low-profile, custom-calibrated device enables patients to use their own strength for movement of the arms.
CLINICAL PERSPECTIVES
Marny Farrell
Director of Rehabilitation, Regions Hospital
"Watching a patient progress into doing more on their own is an amazing and empowering thing"
ABILITECH HEROES
Everyday people who do and overcome the extraordinary. To many, these individuals are spouses, colleagues, teachers, parents, siblings and friends. To us, they are heroes.
The #AbilitechHero of the week is Dr. James Spendley, Medical Director of Spinal Cord Injury Rehabilitation at Courage Kenny Rehabilitation Institute (CKRI). Dr. Spendley and the CKRI team collaborated with Abilitech on an NIH funded research project focused on the development of a fully robotic assist device, and he has been an integral collaborator throughout the development process of the #AbilitechAssist device. He is our hero!
The #AbilitechHero of the week is Dr. Molly Stark of the University of Minnesota Twin Cities. Dr. Stark is a physical therapist at the Wellstone Muscular Dystrophy Center where she provides care for those living with neuromuscular weakness and will support a 35 patient study of the Abilitech Assist this year. Dr. Stark is another front-line worker that is our hero!
The #AbilitechHero of the week is Dr. Leah Hanson of HealthPartners! Dr. Hanson is a leader in the field of neurodegenerative disorders. Her guidance throughout our grant process has been incredible and we know her continued research will be a great resource to us at Abilitech and to many others– you are a hero!
The #AbilitechHero of the week is Dr. James Spendley, Medical Director of Spinal Cord Injury Rehabilitation at Courage Kenny Rehabilitation Institute (CKRI). Dr. Spendley and the CKRI team collaborated with Abilitech on an NIH funded research project focused on the development of a fully robotic assist device, and he has been an integral collaborator throughout the development process of the #AbilitechAssist device. He is our hero!
Meet John! Our #AbilitechHero of the week, John lives with a C3 Spinal Cord Injury (SCI), but is one of the happiest, most optimistic people we know. When John first tested the #AbilitechAssist, he said it was the first time in years that he had even seen his own hand. We know that we can do more for John and many others in similar situations. Thank you, John! You are a hero!
Rob is not only an invaluable member of our team, but he is also one of our #AbilitechHeroes. A spinal cord injury (SCI) left Rob to live with quadriplegia. Rob is determined to stay active in his life and advocate for others living with a similar diagnosis. At Abilitech Medical, Rob’s insight and skills on our devices are second to none. He is paving the way forward for others to have a more active, independent life and that makes him our hero!
#AbiliitechHeroes recognizes Cayden, who has the brightest spirit and the biggest love for video games! Cayden lives with Spinal Muscular Atrophy Type 2 (SMA2) and has helped our team to understand the importance of comfort and usability in our #AbilitechAssist device. You are a hero, Cayden! Keep up the great work
Meet John! Our #AbilitechHero of the week, John lives with a C3 Spinal Cord Injury (SCI), but is one of the happiest, most optimistic people we know. When John first tested the #AbilitechAssist, he said it was the first time in years that he had even seen his own hand. We know that we can do more for John and many others in similar situations. Thank you, John! You are a hero!
CLINICAL TRIALS
Abilitech Medical is committed to clinical research and developing clinical evidence, in collaboration with medical professionals, researchers and industry groups, to support the use of our products and improve the quality of life for patients with upper-limb neuromuscular conditions.
-
Schulze Multi-Center Muscular Dystrophy Ability Study
-
The Schulze Multi-Center Muscular Dystrophy Ability Study is a clinical study that will be conducted at the University of Minnesota and Gillette Children’s Hospital. The study will enroll patients with Muscular Dystrophy with the objective to measure how the Abilitech Assist device can help them complete activities of daily living and impact their quality of life.
-